SC 13G/A | 2024-03-06 | FEDERATED HERMES, INC. | Amphastar Pharmaceuticals, Inc. | 2,165,071 | 4.5% | EDGAR |
SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | Amphastar Pharmaceuticals, Inc. | 2,814,710 | 5.9% | EDGAR |
SC 13G/A | 2024-02-09 | Zhang Jack Y. | Amphastar Pharmaceuticals, Inc. | 13,435,210 | 26.2% | EDGAR |
SC 13G/A | 2024-01-23 | BlackRock Inc. | Amphastar Pharmaceuticals, Inc. | 6,037,158 | 12.6% | EDGAR |
SC 13G/A | 2024-01-17 | FEDERATED HERMES, INC. | Amphastar Pharmaceuticals, Inc. | 3,272,761 | 6.8% | EDGAR |
SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | Amphastar Pharmaceuticals, Inc. | 2,621,807 | 5.4% | EDGAR |
SC 13G/A | 2023-02-01 | FEDERATED HERMES, INC. | Amphastar Pharmaceuticals, Inc. | 3,284,217 | 6.8% | EDGAR |
SC 13G/A | 2023-01-27 | Zhang Jack Y. | Amphastar Pharmaceuticals, Inc. | 13,110,695 | 25.5% | EDGAR |
SC 13G/A | 2023-01-26 | BlackRock Inc. | Amphastar Pharmaceuticals, Inc. | 7,038,769 | 14.6% | EDGAR |
SC 13G/A | 2023-01-20 | BlackRock Inc. | Amphastar Pharmaceuticals, Inc. | 7,038,769 | 14.6% | EDGAR |
SC 13G/A | 2022-02-14 | FEDERATED HERMES, INC. | Amphastar Pharmaceuticals, Inc. | 3,464,335 | 7.2% | EDGAR |
SC 13G/A | 2022-02-11 | Zhang Jack Y. | Amphastar Pharmaceuticals, Inc. | 12,832,535 | 25.5% | EDGAR |
SC 13G/A | 2022-02-09 | VANGUARD GROUP INC | Amphastar Pharmaceuticals, Inc. | 2,468,111 | 5.2% | EDGAR |
SC 13G/A | 2022-01-28 | BlackRock Inc. | Amphastar Pharmaceuticals, Inc. | 7,160,665 | 15.0% | EDGAR |
SC 13G/A | 2021-02-12 | Zhang Jack Y. | Amphastar Pharmaceuticals, Inc. | 12,487,779 | 25.2% | EDGAR |
SC 13G | 2021-02-12 | FEDERATED HERMES, INC. | Amphastar Pharmaceuticals, Inc. | 3,225,883 | 6.8% | EDGAR |
SC 13G/A | 2021-02-10 | VANGUARD GROUP INC | Amphastar Pharmaceuticals, Inc. | 2,478,027 | 5.2% | EDGAR |
SC 13G/A | 2021-01-26 | BlackRock Inc. | Amphastar Pharmaceuticals, Inc. | 7,144,166 | 15.0% | EDGAR |
SC 13G/A | 2020-02-14 | Zhang Jack Y. | Amphastar Pharmaceuticals, Inc. | 12,997,687 | 26.2% | EDGAR |
SC 13G | 2020-02-11 | VANGUARD GROUP INC | Amphastar Pharmaceuticals, Inc. | 2,363,504 | 5.0% | EDGAR |